Directors’ Report
for the half year ended 30 September 2016
Your directors present their report on Innate Immunotherapeutics Limited (the “Company”) and its subsidiary Innate Immunotherapeutics (NZ) Limited (together the “Group”) for the half year ended 30 September 2016.
To view Report please download PDF attached:
Download this document
